JPMorgan Chase sold 51,298 shares of Choice Hotels International in Q3 2025, trimming its position 12.7% to 352,422 shares valued at $37.7 million. One institutional investor rebalancing a $1.59 trillion portfolio is noise. The signal is everything around it.

Analyst consensus on CHH sits at "Reduce" with an average target of $111.36. Two buys. Nine holds. Four sells. JPMorgan's own analyst upgraded the stock from "Underweight" to "Neutral" in December 2025 while cutting the price target to $95. That's not optimism. That's a reclassification from "actively dislike" to "tolerate." The March 2026 bump back to $102 still sits below the current $103.87 close. CFO Scott Oaksmith sold 600 shares on March 17 at roughly $100.07 per share. Insiders sell for many reasons. The timing alongside institutional trimming tells you something.

Q4 2025 earnings looked strong on the surface. Adjusted EPS of $1.60 beat the $1.54 forecast. Revenue hit $390 million against $348.19 million expected. Full-year adjusted EBITDA reached a record $625.6 million. But domestic RevPAR declined 2.2% in Q4 (adjusted for a hurricane benefit in the prior year), driven by softer government and international inbound demand. Record EBITDA at a franchisor while domestic unit economics weaken is a familiar structure. The franchisor collects fees on gross revenue. The owner absorbs the margin compression. Those two parties are not having the same quarter.

Choice's growth story is now overwhelmingly international and conversion-driven. Global openings grew 14% in 2025. International net rooms up 12.5%. The 2026 EPS guidance of $6.92 to $7.14 bakes in continued expansion. At $103.87, the stock trades at roughly 14.5x to 15x forward earnings. Not cheap for a franchisor with a domestic RevPAR headwind and a consensus rating that says "Reduce." Pipeline announcements are compelling narratives. Letters of intent are not contracts. I will never stop saying this.

The 52-week range of $84.04 to $136.45 tells you the market hasn't decided what Choice is worth. A $52 spread on a $100 stock is 50% variance. That's not a range. That's an argument. Institutional investors own 65.57% of float, and when the largest ones trim, the question for hotel owners and operators inside the Choice system isn't whether JPMorgan's portfolio managers know something. It's whether the fee structure and loyalty delivery justify what you're paying when the domestic demand environment softens. Record franchisor EBITDA and declining domestic RevPAR can coexist on the same earnings call. They cannot coexist indefinitely in the same owner's P&L.

Citigroup cut 362,632 shares of RLJ Lodging Trust in Q3, a 56% reduction that left it holding $2.05 million in stock. That's 0.17% of a company with a $1.2 billion market cap. Let's be honest about scale: this is not Citi making a dramatic call on lodging REITs. This is Citi cleaning out a position that barely registered on its book.

The real number is RLJ's full-year 2025 net income to common shareholders: $3.4 million. Down from $42.9 million in 2024. That's a 92% decline. On a portfolio of premium-branded, focused-service hotels in major urban markets. Q4 comparable RevPAR fell 1.5% year-over-year to $136.79. The company beat adjusted FFO estimates ($0.32 vs. $0.28 expected), which tells you the Street's expectations were already low. Beating a low bar is not a thesis.

Let's decompose the owner's return here. RLJ carries $2.2 billion in debt at a weighted average rate of 4.6%. That's roughly $101 million in annual interest expense against $3.4 million in net income. The refinancing completed in February 2026 extended maturities through 2028, which removes near-term default risk but doesn't change the fundamental math: this portfolio is servicing debt, not generating equity returns. The 7.6% dividend yield at $7.87 per share looks attractive until you ask how long a company earning $3.4 million can sustain distributions that imply a significantly higher payout. Check again.

What's instructive is the divergence in institutional behavior. JPMorgan increased its position by 4.5% in the same quarter Citi was selling. Vanguard holds 13.5%. BlackRock holds 11.2%. Institutional ownership sits at 92.35%. These are not dumb holders. They see the 2026 guidance (0.5%-3% RevPAR growth, $1.21-$1.41 adjusted FFO per share) and they're making a bet that the cycle turns. Maybe it does. But 0.5% RevPAR growth on the low end, against expense inflation that RLJ itself called "choppy," means margin compression is the base case for owners. Revenue growth without margin improvement is a treadmill (I've audited this exact dynamic at three different REITs... the top line moves, the bottom line doesn't, and the management company still collects its fee).

Analysts have a consensus "Hold" with an $8.64 target. That's 16% upside from $7.43. In a sector trading near historic lows with 92% institutional ownership, the question isn't whether RLJ survives. It's whether the owner's actual return... after management fees, franchise fees, FF&E reserves, CapEx, and debt service... justifies holding the equity at these levels. The math works if you believe the cycle inflects in late 2026. If it doesn't, $3.4 million in net income on a $1.2 billion market cap is a 0.28% return on equity. That's not a lodging investment. That's a parking lot for capital waiting for something better.